elCID and COVID-19 [COVID-19]
Research type
Research Study
Full title
Extending the electronic Clinical Infection Database (eLCID) tool to support clinicians and researchers in the COVID-19 response.
IRAS ID
283831
Contact name
Emmanuel Wey
Contact email
Sponsor organisation
Royal Free London NHS Foundation Trust
Eudract number
2020-000936-23
Duration of Study in the UK
1 years, 6 months, 0 days
Research summary
This project relates to COVID-19, and is an urgent public health study.
The coronavirus disease 2019 (COVID-19) pandemic has profoundly affected healthcare across the world. In the UK as of 28nd April 2020 there were approximately 160,000 laboratory confirmed cases of SARS-CoV-2. This is an underestimate of the disease burden as many infected people outside of acute healthcare settings have not been tested, and some early test swabs results were likely false negatives. Of those hospitalised with a positive test, over 21,000 have died. The epicentre of the disease is London, and the Royal Free London has been heavily involved in patient care and management.
elCID is a clinical governance and patient safety tool in current use that can be adapted to enable more effective COVID-19 related research to be undertaken within the Trust as part of the rapid response to the pandemic.
Following a demonstration of the clinical usefulness of the eLCID system, clinicians across the Trust are keen to have access to the tool. Its provision will ensure that departments are able to use eLCID to support clinical governance and patient safety in the COVID-19 response.The tool will also support recruitment to NIHR/UKRI-supported national trials as well as innovative projects that originate from multiple specialties in the Trust and its research services. It is hoped that the extension of elCID use will improve our knowledge and understanding of the care and management of people with or at risk of COVID-19.
REC name
N/A
REC reference
N/A